Tonev D, Viiachki I
Khirurgiia (Sofiia). 1998;51(1):33-40.
Over a one-year period (Nov. 1996-Nov. 1997), a total of 154 patients are admitted on an emergency basis, with deferred emergency and for routine treatment in the Clinic of Emergency Surgery. They are distributed in three groups, as follows: patients not requiring perioperative antibiotic prophylaxis and postoperative antibiotic therapy--27, patients subjected to perioperative parenteral antibiotic prophylaxis under adequate hospital conditions--121, and patients undergoing antibiotic prophylaxis in conditions inappropriate for its application--six. The drug schemes elaborated are in conformity with worldwide and Bulgarian experience along this line, and with the concrete hospital and economical conditions in this country. In all patient indicated for antibiotic prophylaxis the listed below antibacterial agents (presented as drug schemes) are administered i.v. a single time prior to anesthesia induction: in operations on the gastrointestinal tract except for interventions in acute appendicitis: cephalotin/cefazolin 2.0 g and metronidazole 0.5 g i.v.; in operations for acute appendicitis: amoxicillin/clavulanate 1.2 g and petronidazole 0.5 f i.v.; biliary surgery free of extrahepatic cholestasis: cephalotin/cefazolin 2.0 g i.v.; biliary surgery with present or preceding extrahepatic cholestasis: cefotetan 2 g i.v.; contaminated liver cysts (parasitic and nonparasitic): cefotetan 2 g i.v.; abdominal trauma without perforation of a hollow organ: cefotetan 2 g i.v.; in plastic repair of the anterior abdominal wall (congenital defects, postoperative eventration) and in poor risk patients (local and general status: cephalotin/cefazolin 2.0 g i.v. In 135 patients the postoperative period runs a course free of complications worthy of notice. Complications directly linked to introduction of the method proposed are recorded in ten cases: operative wound suppuration (4) and hospital infection (6). Complications not related directly to the procedure are observed in nine cases: urinary tract infection (4), bronchopneumonia (2), fever with unknown source of infection (including negative hemoculture) necessitating additional antibiotic therapy (2) and secondary infection (within a week of intervention) necessitating further therapy with antibiotics. The specific features of antibiotic prophylaxis used in the various types of operative interventions are discussed from microbiological, clinical and pharmacotherapeutic viewpoints. The obtained results are compared with pertinent literature data on the issue with a special reference to the clinical efficacy attained. They mirror the approach against the background of the concrete hospital conditions in this country. The method developed is fully consistent with the level of surgical expertise in Bulgaria. All efforts should be aimed at intrahospital environment improvement by means of meticulous asepsis and antisepsis.
在一年期间(1996年11月至1997年11月),共有154例患者在急诊外科诊所接受急诊、延期急诊和常规治疗。他们被分为三组,如下:不需要围手术期抗生素预防和术后抗生素治疗的患者——27例,在充分的医院条件下接受围手术期胃肠外抗生素预防的患者——121例,以及在不适合应用抗生素的条件下接受抗生素预防的患者——6例。所制定的用药方案符合全球和保加利亚在这方面的经验,以及该国具体的医院和经济状况。在所有需要抗生素预防的患者中,以下列出的抗菌药物(以用药方案形式呈现)在麻醉诱导前静脉注射一次:在胃肠道手术中,除急性阑尾炎手术外:头孢噻吩/头孢唑林2.0g和甲硝唑0.5g静脉注射;在急性阑尾炎手术中:阿莫西林/克拉维酸1.2g和哌拉甲硝唑0.5g静脉注射;无肝外胆汁淤积的胆道手术:头孢噻吩/头孢唑林2.0g静脉注射;有或曾有肝外胆汁淤积的胆道手术:头孢替坦2g静脉注射;污染性肝囊肿(寄生虫性和非寄生虫性):头孢替坦2g静脉注射;无中空器官穿孔的腹部创伤:头孢替坦2g静脉注射;在前腹壁整形修复术(先天性缺陷、术后切口疝)以及高危患者(局部和全身状况)中:头孢噻吩/头孢唑林2.0g静脉注射。135例患者术后期间未出现值得注意的并发症。与所提议方法的应用直接相关的并发症在10例中被记录:手术伤口化脓(4例)和医院感染(6例)。在9例中观察到与手术过程无直接关系的并发症:尿路感染(4例)、支气管肺炎(2例)、不明感染源发热(包括血培养阴性)需要额外抗生素治疗(2例)以及继发感染(干预后一周内)需要进一步抗生素治疗。从微生物学、临床和药物治疗学角度讨论了在各种手术干预中使用抗生素预防的具体特点。将所得结果与该问题的相关文献数据进行比较,特别提及所达到的临床疗效。它们反映了在该国具体医院条件背景下的方法。所开发的方法与保加利亚的外科专业水平完全一致。所有努力都应旨在通过细致的无菌操作和防腐措施改善医院内环境。